Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Handa

Showing results (261-270 of 340) with videos related to

Pageof 34
Sort By:
JCI Insight|December 13, 2019
LXRs regulate features of age-related macular degeneration and may be a potential therapeutic targetMayur Choudhary, Ebraheim N Ismail, Pei-Li Yao, et al.
Plos One|March 4, 2014
T cells and macrophages responding to oxidative damage cooperate in pathogenesis of a mouse model of age-related macular degenerationFernando Cruz-Guilloty, Ali M Saeed, Stephanie Duffort, et al.
Frontiers in Immunology|June 29, 2026
Case Report: Bilateral optic nerve head masses and retinopathy in a patient with B-cell acute lymphoblastic leukemia receiving CAR T-cell therapy masquerading as fungal endophthalmitisJacob S Heng, Eugenia Ramos-Davila, Alejandra M Maiz, et al.
Investigative Ophthalmology & Visual Science|August 12, 2018
A Role for βA3/A1-Crystallin in Type 2 EMT of RPE Cells Occurring in Dry Age-Related Macular DegenerationSayan Ghosh, Peng Shang, Hiroto Terasaki, et al.
BMC Pharmacology & Toxicology|January 16, 2013
Vascular disrupting agent for neovascular age related macular degeneration: a pilot study of the safety and efficacy of intravenous combretastatin A-4 phosphateMohamed A Ibrahim, Diana V Do, Yasir J Sepah, et al.
Oncotarget|January 14, 2016
Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanomaKe Hu, Savalan Babapoor-Farrokhran, Murilo Rodrigues, et al.
Oncotarget|March 22, 2021
Correction: Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanomaKe Hu, Savalan Babapoor-Farrokhran, Murilo Rodrigues, et al.
The British Journal of Ophthalmology|October 8, 2021
Effects of fetal haemoglobin on systemic oxygenation in preterm infants and the development of retinopathy of prematurity PacIFiHER Report No. 2Kim Jiramongkolchai, Michael X Repka, Jing Tian, et al.
Journal of Vitreoretinal Diseases|April 3, 2023
Patient Use of Dietary Supplements, Home Monitoring, or Genetic Testing for Nonneovascular Age-Related Macular DegenerationBrittany C Tsou, T Y Alvin Liu, Jun Kong, et al.
Cells|November 26, 2022
Microglia-Neutrophil Interactions Drive Dry AMD-like Pathology in a Mouse ModelMaeve Boyce, Ying Xin, Olivia Chowdhury, et al.
Pageof 34

Showing results (261-270 of 340) with videos related to

Sort By:
Pageof 34
JCI Insight|December 13, 2019
LXRs regulate features of age-related macular degeneration and may be a potential therapeutic targetMayur Choudhary, Ebraheim N Ismail, Pei-Li Yao, et al.
Plos One|March 4, 2014
T cells and macrophages responding to oxidative damage cooperate in pathogenesis of a mouse model of age-related macular degenerationFernando Cruz-Guilloty, Ali M Saeed, Stephanie Duffort, et al.
Frontiers in Immunology|June 29, 2026
Case Report: Bilateral optic nerve head masses and retinopathy in a patient with B-cell acute lymphoblastic leukemia receiving CAR T-cell therapy masquerading as fungal endophthalmitisJacob S Heng, Eugenia Ramos-Davila, Alejandra M Maiz, et al.
Investigative Ophthalmology & Visual Science|August 12, 2018
A Role for βA3/A1-Crystallin in Type 2 EMT of RPE Cells Occurring in Dry Age-Related Macular DegenerationSayan Ghosh, Peng Shang, Hiroto Terasaki, et al.
BMC Pharmacology & Toxicology|January 16, 2013
Vascular disrupting agent for neovascular age related macular degeneration: a pilot study of the safety and efficacy of intravenous combretastatin A-4 phosphateMohamed A Ibrahim, Diana V Do, Yasir J Sepah, et al.
Oncotarget|January 14, 2016
Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanomaKe Hu, Savalan Babapoor-Farrokhran, Murilo Rodrigues, et al.
Oncotarget|March 22, 2021
Correction: Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanomaKe Hu, Savalan Babapoor-Farrokhran, Murilo Rodrigues, et al.
The British Journal of Ophthalmology|October 8, 2021
Effects of fetal haemoglobin on systemic oxygenation in preterm infants and the development of retinopathy of prematurity PacIFiHER Report No. 2Kim Jiramongkolchai, Michael X Repka, Jing Tian, et al.
Journal of Vitreoretinal Diseases|April 3, 2023
Patient Use of Dietary Supplements, Home Monitoring, or Genetic Testing for Nonneovascular Age-Related Macular DegenerationBrittany C Tsou, T Y Alvin Liu, Jun Kong, et al.
Cells|November 26, 2022
Microglia-Neutrophil Interactions Drive Dry AMD-like Pathology in a Mouse ModelMaeve Boyce, Ying Xin, Olivia Chowdhury, et al.
Pageof 34